Dr. Thomas McGinn answers questions on comorbidities that are key factors in the acuity of COVID-19
Dr. Thomas McGinn, the director of Health Innovations & Outcomes Research at Feinstein Institutes, spoke with News 12's Elizabeth Hashagen and answered COVID-19 questions from viewers.
•
Apr 29, 2020, 1:38 PM
•
Updated 1,889 days ago
Share:
Dr. Thomas McGinn, the director of Health Innovations & Outcomes Research at Feinstein Institutes, spoke with News 12's Elizabeth Hashagen and answered COVID-19 questions from viewers.
Dr. McGinn was co-author on a JAMA paper about a study that linked hypertension, obesity and diabetes as comorbidities (the simultaneous presence of two chronic diseases or conditions in a patient) as key factors in the acuity of COVID-19 in some patients.
More from News 12
1:57
Independent divers find car in Mount Sinai Harbor with human remains inside
1:48
STORM WATCH: Hot, humid and scattered afternoon and evening thunderstorms for Long Island
0:42
Memorial Sloan Kettering, UnitedHealthcare reach multiyear agreement to ensure continued in-network service for LI cancer patients
Jury says it reached verdict on 4 of 5 counts in Sean 'Diddy' Combs trial, judge indicates they'll keep deliberating
1:34
Guide to free Fourth of July firework shows on Long Island
0:52
